Study of XL647 Administered Orally Daily to Patients With Solid Tumors - Related Studies

Home

Study of XL647 Administered Orally Daily to Patients With Solid Tumors

This study is ongoing, but not recruiting participants.

Study NCT00336765. Last updated on June 18, 2008. Information provided by Exelixis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer

2	Interventions listed in this trial
		XL647

3	Sponsors listed in this trial
		Exelixis